First surveillance of malaria among seafarers: evaluation of incidence and identification of risk areas.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
06 09 2019
06 09 2019
Historique:
received:
20
06
2019
accepted:
12
09
2019
entrez:
4
10
2019
pubmed:
4
10
2019
medline:
1
9
2020
Statut:
epublish
Résumé
Malaria is a potentially deadly parasitosis. Due to its geographical distribution, seafarers are particularly exposed to it. This study is an epidemiological analysis on the morbidity of malaria onboard commercial ships without a physician, with the purpose of proposing solutions aimed at limiting further infections in this delicate and difficult working environment. We examined 17,212 health records of patients embarked on ships assisted by the CIRM from 2011 to 2015. All the diagnosed diseases have been categorized based on the ICD-10 classification system by the WHO. This study analyzed the cases of suspected malaria and the cases of malaria confirmed by clinical tests. The geographical distribution of infections and the drugs chosen by physicians are also assessed. Although a reduction in malaria cases was appreciated during the 5-year period taken into consideration, this disease still covers an important percentage of all infectious diseases that occurred onboard. This proves that it is a major health problem for seafarers. In order to protect seafarers' population, strengthen malaria prevention and control programs, as well to improve the availability of antimalarial drugs onboard ships is necessary. This may ensure rapid and efficient health interventions in case of need.
Identifiants
pubmed: 31580330
doi: 10.23750/abm.v90i3.8612
pmc: PMC7233751
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
378-384Références
Trop Med Int Health. 2005 Sep;10(9):909-18
pubmed: 16135199
Bull Inst Marit Trop Med Gdynia. 1998;49(1-4):63-71
pubmed: 10431647
Acta Trop. 2007 May;102(2):126-37
pubmed: 17543264
Occup Med (Lond). 2016 Mar;66(2):135-7
pubmed: 26409049
Eur Rev Med Pharmacol Sci. 2018 Jul;22(13):4392-4400
pubmed: 30024631
Crit Care. 2003 Aug;7(4):315-23
pubmed: 12930555
Int Marit Health. 2002;53(1-4):7-17
pubmed: 12608584
Travel Med Infect Dis. 2012 Jul;10(4):186-91
pubmed: 22819258
J Travel Med. 2000 Nov-Dec;7(6):309-13
pubmed: 11179952
Lancet. 2005 Apr 23-29;365(9469):1487-98
pubmed: 15850634
Int Marit Health. 1999;50(1-4):7-13
pubmed: 10970266
Int Marit Health. 2013;64(3):160-7
pubmed: 24072544
Bull Inst Marit Trop Med Gdynia. 1998;49(1-4):53-61
pubmed: 10431646
Malar J. 2011 Dec 20;10:378
pubmed: 22185615
Int Marit Health. 2012;63(1):24-31
pubmed: 22669809
Int Marit Health. 2001;52(1-4):9-18
pubmed: 11817846
Ann Ig. 2018 Mar-Apr;30(2):162-172
pubmed: 29465153
Int Marit Health. 2018;69(1):28-34
pubmed: 29611611
Asian Pac J Trop Med. 2011 Jun;4(6):498-504
pubmed: 21771707
Int Marit Health. 2016;67(1):21-3
pubmed: 27029925
J Antimicrob Chemother. 2007 Nov;60(5):929-36
pubmed: 17848375
J Telemed Telecare. 1998;4 Suppl 1:44-5
pubmed: 9640732
Scand J Infect Dis. 1996;28(2):107-10
pubmed: 8792473
Lancet. 1990 Jan 20;335(8682):164
pubmed: 1967449
Int Marit Health. 2009;60(1-2):29-32
pubmed: 20205124